<i>In vitro</i> elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumabSara Caratelli, Giuseppe Sconocchia|International Journal of Cancer|2019Cited by 40
CD16-158-Valine Chimeric Receptor T Cells Overcome the Resistance of KRAS-mutated Colorectal Carcinoma Cells to CetuximabRoberto Arriga, Giuseppe Sconocchia|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 3
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicitySara Caratelli, Giuseppe Sconocchia|Experimental Hematology and Oncology|2025Cited by 2
Antibody-Independent Antitumor Effects of Cd32A-Chimeric Receptor T Cells: Implications for Breast Cancer Prognosis and TreatmentGiuseppe Sconocchia, Giulio C. Spagnoli|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1
Elimination of Egfr-Overexpressing Cancer Cells by CD32 Chimeric Receptor T Cells in Combination with Cetuximab or PanitumumabSara Caratelli, Giuseppe Sconocchia|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 0